Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Oxbridge Re Holdings (OXBR) EBT (2016 - 2025)

Oxbridge Re Holdings (OXBR) has disclosed EBT for 12 consecutive years, with -$172000.0 as the latest value for Q3 2025.

  • On a quarterly basis, EBT rose 82.95% to -$172000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.7 million, a 64.73% increase, with the full-year FY2024 number at -$1.6 million, up 82.66% from a year prior.
  • EBT was -$172000.0 for Q3 2025 at Oxbridge Re Holdings, up from -$2.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $8.7 million in Q4 2021 to a low of -$7.1 million in Q3 2023.
  • A 5-year average of -$362263.2 and a median of -$172000.0 in 2025 define the central range for EBT.
  • Peak YoY movement for EBT: surged 3742.29% in 2021, then crashed 5766.67% in 2024.
  • Oxbridge Re Holdings' EBT stood at $8.7 million in 2021, then crashed by 92.22% to $679000.0 in 2022, then plummeted by 459.5% to -$2.4 million in 2023, then surged by 126.26% to $641000.0 in 2024, then tumbled by 126.83% to -$172000.0 in 2025.
  • Per Business Quant, the three most recent readings for OXBR's EBT are -$172000.0 (Q3 2025), -$2.0 million (Q2 2025), and -$125000.0 (Q1 2025).